Esperion Therapeutics
ESPR
#6975
Rank
C$0.66 B
Marketcap
$3.37
Share price
7.83%
Change (1 day)
-8.27%
Change (1 year)

Esperion Therapeutics (ESPR) - P/B ratio

P/B ratio as of January 2025 : -1.19

According to Esperion Therapeutics's latest financial reports the company has a price-to-book ratio of 1.49718.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Esperion Therapeutics - P/B ratio (from 2013 to 2024)

2016201920222025501001500companiesmarketcap.com

P/B ratio by year

Year P/B ratio Change
2024-12-31-1.2162.38%
2023-12-31-0.7473-47.29%
2022-12-31-1.42-8.3%
2021-12-31-1.55-77.94%
2020-12-31-7.01-108.53%
2019-12-3182.2426.99%
2018-12-3115.6121.25%
2017-12-317.05470.68%
2016-12-311.24-29.21%
2015-12-311.74-71.67%
2014-12-316.16116.53%
2013-12-312.84
2012-12-31N/A
2003-12-31N/A
2002-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
11.0-1,018.70%๐Ÿ‡บ๐Ÿ‡ธ USA
2.34-295.94%๐Ÿ‡บ๐Ÿ‡ธ USA
1.65-238.15%๐Ÿ‡บ๐Ÿ‡ธ USA
2.62-319.27%๐Ÿ‡บ๐Ÿ‡ธ USA
15.0-1,355.11%๐Ÿ‡บ๐Ÿ‡ธ USA
1.53-228.31%๐Ÿ‡บ๐Ÿ‡ธ USA